An Australian innovation in 3D printing could soon help in the fight against cancer.

Sydney based start-up Inventia has built a new 3D bio-printer that it says removes the need for time-consuming manual labour by medical lab workers.

Known as Rastrum, the pink printer emulates ink-jet technology to print human cells at a rapid rate – quickly cultivating realistic tumours for testing cancer drugs.

It can also conduct multiple experiments at the same time.

“One of the comments we had from a researcher was he was able to produce more cell models with Rastrum in a few weeks than he previously produced in an entire PhD,” Cameron Ferris, Inventia’s chief operating officer, said.

“We hope that this will turbocharge cancer research.”

Kaylene Simpson, head of the Victorian Centre for Functional Genomics (VCFG), said the machine will have a profound impact on the centre’s studies.

“It’s a game changer for us in a discovery-based science … we can screen through thousands of drugs,” she said.

Read more at abc.net.au

Image Credit:    Cameron Gooley

News This Week

New, better coronavirus rapid test

Researchers at the Paul Scherrer Institute PSI and the University of Basel have developed a rapid test for COVID-19. Its novel functional principle promises reliable and quantifiable results concerning a patient's COVID-19 disease and [...]

Nanocomposite Hydrogel Improves Bone Repair Treatment

Innovative researchers have investigated the potential of incorporating a gelatin methacryloyl hydrogel functionalized with synthetic nanoclay laponite to improve the delivery of osteoblast derived extracellular vesicles for increased bone repair. This research has been [...]

Applying Nanoemulsions to the Food Sector

Nanoemulsions are a relatively new technology that has found significant use for delivering functional chemicals such as micronutrients, flavorings, bioactive molecules, and antimicrobial agents into food and beverage products. This article focuses on applying [...]